New ‘Dark Genome’ Biotech Gets Backing From Big Pharma Venture Funds

Autoimmune Diseases Will Be First Target

 
• By Andrew McConaghie
  
DNA helix
'Dark matter' makes up 98% of the genome, but until now its influence on disease has not been well understood. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Business